Back to LA LINDEN ADVISORS LP
ASASCENDIS PHARMA A/S
Showing 8 of 13 quarters
Position history for LALINDEN ADVISORS LP's holdings in ASCENDIS PHARMA A/S
As of its Q1 2026 13F, Linden Advisors held 139,570,000 shares of ASCENDIS PHARMA, worth $205.5M. Linden Advisors' 13F filings listed ASCENDIS PHARMA from Q2 2023 to Q1 2026, 12 quarterly filings. ASCENDIS PHARMA was 1.2% of Linden Advisors' reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$204.7M
Total Shares Change
-175.2M
Quarter-by-Quarter History